FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004307865> ?p ?o ?g. }

• W2004307865 abstract "The bone morphogenetic proteins (BMPs) belong to a unique group of proteins that includes the growth factor TGF-β. BMPs play important roles in cell differentiation, cell proliferation, and inhibition of cell growth. They also participate in the maturation of several cell types, depending on the microenvironment and interactions with other regulatory factors. Depending on their concentration gradient, the BMPs can attract various types of cells and act as chemotactic, mitogenic, or differentiation agents. BMPs can interfere with cell proliferation and the formation of cartilage and bone. In addition, BMPs can induce the differentiation of mesenchymal progenitor cells into various cell types, including chondroblasts and osteoblasts. The aim of this study was to analyze the effects of treatment with rhBMP-2 on the proliferation of canine mesenchymal stem cells (cMSCs) and the tumor suppression properties of rhBMP-2 in canine osteocarcoma (OST) cells. Osteosarcoma cell lines were isolated from biopsies and excisions of animals with osteosarcoma and were characterized by the Laboratory of Biochemistry and Biophysics, Butantan Institute. The mesenchymal stem cells were derived from the bone marrow of canine fetuses (cMSCs) and belong to the University of São Paulo, College of Veterinary Medicine (FMVZ-USP) stem cell bank. After expansion, the cells were cultured in a 12-well Transwell system; cells were treated with bone marrow mesenchymal stem cells associated with rhBMP2. Expression of the intracytoplasmic and nuclear markers such as Caspase-3, Bax, Bad, Bcl-2, Ki-67, p53, Oct3/4, Nanog, Stro-1 were performed by flow citometry.We evaluated the regenerative potential of in vitro treatment with rhBMP-2 and found that both osteogenic induction and tumor regression occur in stem cells from canine bone marrow. rhBMP-2 inhibits the proliferation capacity of OST cells by mechanisms of apoptosis and tumor suppression mediated by p53.We propose that rhBMP-2 has great therapeutic potential in bone marrow cells by serving as a tumor suppressor to increase p53 and the pro-apoptotic proteins Bad and Bax, as well as by increasing the activity of phosphorylated caspase 3.Canine bone marrow mesenchymal stem cells associated with rhBMP2 in canine osteosarcoma treatment: in vitro study." @default.
• W2004307865 created "2016-06-24" @default.
• W2004307865 creator A5004450986 @default.
• W2004307865 creator A5012287106 @default.
• W2004307865 creator A5016177211 @default.
• W2004307865 creator A5049410743 @default.
• W2004307865 creator A5066085944 @default.
• W2004307865 creator A5068732758 @default.
• W2004307865 creator A5072781436 @default.
• W2004307865 date "2012-02-22" @default.
• W2004307865 modified "2023-10-14" @default.
• W2004307865 title "Mesenchymal stem cells with rhBMP-2 inhibits the growth of canine osteosarcoma cells" @default.
• W2004307865 cites W1574963476 @default.
• W2004307865 cites W1968822620 @default.
• W2004307865 cites W1972191225 @default.
• W2004307865 cites W1975806246 @default.
• W2004307865 cites W1991095294 @default.
• W2004307865 cites W2000959419 @default.
• W2004307865 cites W2010815972 @default.
• W2004307865 cites W2012599325 @default.
• W2004307865 cites W2024116911 @default.
• W2004307865 cites W2037555056 @default.
• W2004307865 cites W2040471138 @default.
• W2004307865 cites W2040861999 @default.
• W2004307865 cites W2056105211 @default.
• W2004307865 cites W2057839193 @default.
• W2004307865 cites W2060739562 @default.
• W2004307865 cites W2073759231 @default.
• W2004307865 cites W2080248100 @default.
• W2004307865 cites W2080838269 @default.
• W2004307865 cites W2093654042 @default.
• W2004307865 cites W2100221605 @default.
• W2004307865 cites W2121086400 @default.
• W2004307865 cites W2121848695 @default.
• W2004307865 cites W2149095266 @default.
• W2004307865 cites W2168478740 @default.
• W2004307865 cites W4245862414 @default.
• W2004307865 cites W4252806092 @default.
• W2004307865 doi "https://doi.org/10.1186/1746-6148-8-17" @default.
• W2004307865 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3307475" @default.
• W2004307865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22356869" @default.
• W2004307865 hasPublicationYear "2012" @default.
• W2004307865 type Work @default.
• W2004307865 sameAs 2004307865 @default.
• W2004307865 citedByCount "22" @default.
• W2004307865 countsByYear W20043078652012 @default.
• W2004307865 countsByYear W20043078652014 @default.
• W2004307865 countsByYear W20043078652015 @default.
• W2004307865 countsByYear W20043078652016 @default.
• W2004307865 countsByYear W20043078652017 @default.
• W2004307865 countsByYear W20043078652018 @default.
• W2004307865 countsByYear W20043078652019 @default.
• W2004307865 countsByYear W20043078652020 @default.
• W2004307865 countsByYear W20043078652021 @default.
• W2004307865 countsByYear W20043078652022 @default.
• W2004307865 crossrefType "journal-article" @default.
• W2004307865 hasAuthorship W2004307865A5004450986 @default.
• W2004307865 hasAuthorship W2004307865A5012287106 @default.
• W2004307865 hasAuthorship W2004307865A5016177211 @default.
• W2004307865 hasAuthorship W2004307865A5049410743 @default.
• W2004307865 hasAuthorship W2004307865A5066085944 @default.
• W2004307865 hasAuthorship W2004307865A5068732758 @default.
• W2004307865 hasAuthorship W2004307865A5072781436 @default.
• W2004307865 hasBestOaLocation W20043078651 @default.
• W2004307865 hasConcept C104317684 @default.
• W2004307865 hasConcept C185592680 @default.
• W2004307865 hasConcept C198826908 @default.
• W2004307865 hasConcept C201750760 @default.
• W2004307865 hasConcept C203014093 @default.
• W2004307865 hasConcept C2777760704 @default.
• W2004307865 hasConcept C28328180 @default.
• W2004307865 hasConcept C31507581 @default.
• W2004307865 hasConcept C502942594 @default.
• W2004307865 hasConcept C55493867 @default.
• W2004307865 hasConcept C62112901 @default.
• W2004307865 hasConcept C86803240 @default.
• W2004307865 hasConcept C95444343 @default.
• W2004307865 hasConceptScore W2004307865C104317684 @default.
• W2004307865 hasConceptScore W2004307865C185592680 @default.
• W2004307865 hasConceptScore W2004307865C198826908 @default.
• W2004307865 hasConceptScore W2004307865C201750760 @default.
• W2004307865 hasConceptScore W2004307865C203014093 @default.
• W2004307865 hasConceptScore W2004307865C2777760704 @default.
• W2004307865 hasConceptScore W2004307865C28328180 @default.
• W2004307865 hasConceptScore W2004307865C31507581 @default.
• W2004307865 hasConceptScore W2004307865C502942594 @default.
• W2004307865 hasConceptScore W2004307865C55493867 @default.
• W2004307865 hasConceptScore W2004307865C62112901 @default.
• W2004307865 hasConceptScore W2004307865C86803240 @default.
• W2004307865 hasConceptScore W2004307865C95444343 @default.
• W2004307865 hasIssue "1" @default.
• W2004307865 hasLocation W20043078651 @default.
• W2004307865 hasLocation W20043078652 @default.
• W2004307865 hasLocation W20043078653 @default.
• W2004307865 hasLocation W20043078654 @default.
• W2004307865 hasOpenAccess W2004307865 @default.
• W2004307865 hasPrimaryLocation W20043078651 @default.
• W2004307865 hasRelatedWork W2051452745 @default.
• W2004307865 hasRelatedWork W2135793203 @default.
• W2004307865 hasRelatedWork W2289822130 @default.

• next